( February 17, 2026, 8:02 AM EST) -- LOS ANGELES — A California federal judge found that Eli Lilly & Co. does not have standing under the Lanham Act to sue a telehealth company over its sale of compounded tirzepatide products, granting a motion to dismiss with prejudice and without leave to amend....